diabetes

Terri Doss, second from right, a research assistant at the Vanderbilt Mouse Metabolic Phenotyping Center, received the Robert K. Hall Service Award for her outstanding contributions to the diabetes research community. Young investigators receiving awards at Diabetes Day are, left to right, Kathryn Snyder, MD, MPH; Darian Carroll; Doss and Dudley McNitt, PhD. Not pictured is Emily Hawes, PhD. (photo by Susan Urmy)

Diabetes Day spotlights achievements, current investigations

Today, the Vanderbilt Diabetes Research and Training Center includes 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research on the cause, prevention, treatment and complications of diabetes and obesity.

Teams to create one-stop resource for human pancreatic data to foster diabetes research

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research.

From left, John Kuriyan, PhD, Vanderbilt Prize recipient Frances Ashcroft, PhD, Vanderbilt Prize Student Scholar Yasminye Pettway, Kathleen Gould, PhD, and Jennifer Pietenpol, PhD. (photo by Donn Jones)

Vanderbilt Prize winner’s lecture focused on the joy of discovery

During her Discovery Lecture on March 21, Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, spoke on the joy science has given her.

GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes

The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.

Study links small pancreas size to faster progression to stage 3 Type 1 diabetes

The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials.

A biomarker for early Type 2 diabetes

Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.

1 2 3 18